Hellow guys, Welcome to my website, and you are watching Real-world safety analysis of deferi****e in patients with MDS. and this vIdeo is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2023-01-13T02:57:51-08:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Real-world safety analysis of deferi****e in patients with MDS |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 13-01-2023 05:57:51 |
| Video Discription | Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, discusses challenges with iron chelation therapy in patients with myelodysplastic syndromes (MDS) and the need to improve treatment options for these patients. Dr Zeidan then shares some insights into a real-world analysis which investigated the safety of deferi****e in patients with MDS, using data from the US Safety Registry and a compassionate use program. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved. |
| Category | Education |
| Tags | Speaker: Amer Zeidan | Institution: Yale University and Yale Cancer Center | Event: ASH 2022 | Format: Interview | Subject: Myelodysplastic syndromes | Field: Treatment | Field: Real-world data | Medicines: Deferi****e | Medicines: Deferoxamine | Medicines: Deferasirox | neutropenia | anemia | iron chelation | transfusion dependence |
